Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
24/5 00:33
Key PointsSuperstring Capital acquired 730,548 shares of Vir Biotechnology last quarter; the estimated trade size was $5.82 million based on quarterly average prices....